When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.
about
Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cellsThe psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode networkPredicting new molecular targets for known drugsAntidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsThe Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of CivilizationPsychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesRegulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering ratsMethodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.The sigma-1 receptor chaperone as an inter-organelle signaling modulatorLC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate.The chemical basis of pharmacology.Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulusNeuropharmacology of N,N-dimethyltryptamineClinical applications of hallucinogens: A review.Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptorσ1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain.The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.Sigma receptors [σRs]: biology in normal and diseased statesThe Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune CellsThe pharmacology of sigma-1 receptors.Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy.A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis.Risk assessment of dietary exposure to tryptamine for the Austrian population.Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells.Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases.Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion.Involvement of μ- and δ-opioid receptor function in the rewarding effect of (±)-pentazocine.Involvement of the delayed rectifier outward potassium channel Kv2.1 in methamphetamine-induced neuronal apoptosis via the p38 mitogen-activated protein kinase signaling pathway.Inhibitory effects of SA4503 on the rewarding effects of abused drugs.The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.Molecular imaging of σ receptors: synthesis and evaluation of the potent σ1 selective radioligand [18F]fluspidine.Possible involvement of the Sigma-1 receptor chaperone in chemotherapeutic-induced neuropathic pain.Effects of (+)-pentazocine on the antinociceptive effects of (-)-pentazocine in mice.Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
P2860
Q21089664-07802065-233E-41C9-9083-C6FDA066BF28Q21131813-939A3069-B9FB-44A7-9501-58DE4182E891Q24649687-17A04D6B-5D96-49D3-97C1-77B56824088AQ26746137-3D3485E1-0CD6-4E4A-B54F-37547F77EFA8Q26765995-4BFDCFC8-C49F-4299-96C1-D4D1CEA7ED2AQ26799997-ACD3E53D-3FF7-4424-823E-E9474238AA75Q33714937-F1DF3DD7-D129-4AD4-8206-30C316689D79Q33740814-32025500-7A66-47C3-A108-76E87A8BA82EQ34325119-FC55CB34-F0A0-460B-89FF-FE58B61C738FQ34356970-3B3766C4-5012-4E03-B6E8-BF662A5DC0FEQ34359597-DCBA0620-CF83-447D-8ACA-9E721B554C7CQ34363831-8900BF8B-E210-4E35-898A-AA1A35801B8DQ34438529-FF525FA6-7E3D-4738-8BC4-E4A130028448Q34502987-E3B15369-03C2-4602-B8EE-B6BEE6835676Q34524116-CBB9B19E-3699-44BA-9CA1-804C63DC91F2Q34535259-B8F78FF2-E7BC-4280-96B2-8E5707FCD4FFQ34882628-BB856703-6514-4C0E-9340-046B6CDF16DDQ34914351-F4DF9B13-C57B-4F47-A461-7D7B0211306BQ35017184-00520ABE-5E39-415D-B393-EF02B51AE545Q37000551-09FBA57F-9AA5-428D-896C-8954417D8557Q37253512-B1D85F9B-8728-4DB5-8982-EEB000FEFA85Q37445561-4ED63888-14DE-415E-9286-F3F71CDE7BE8Q37777989-B153F1CC-E1F7-4D82-AF48-1FE0EF4A4E98Q37988834-19D27CAD-CC82-4ABF-A619-5D2AC216F05DQ38101865-117A30B2-3EAB-4063-8F0F-3B6A14D466DBQ38704738-0C006AF3-B5DE-4292-B489-2E1C2176D31AQ39069372-DC24C7A0-52BC-4923-AB6A-BBCA16A1108DQ39141333-A19113F3-A2F2-4113-9A52-127D9A3EB3B3Q41714466-05A170F5-71F6-40FE-81D9-BF01D58D5851Q42835492-919EE351-AAB5-40BC-9791-A9838B5023B8Q44346188-930121F8-6393-44C8-95F1-DDE13B1C74B6Q47235441-BBF9890B-4972-4E78-9C66-F211A9ED6D26Q48134726-4D7FC5CD-4C35-46B5-8299-7E981FAE9F04Q50973291-A9052FC8-CC37-4788-93A3-92155475FFFEQ51533029-3CBCC965-20EE-45CC-B6EB-F906B84868DAQ51741747-A12BEB66-4B36-4450-B5F1-5B2E9D85B705Q51745139-923938DB-F6F8-41A6-AB05-598E0CD9FB31Q52757903-009D6039-6946-4332-A221-09A8E67E7163Q57075471-4AA471D8-C571-49BE-8638-7281B0448B16
P2860
When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
When the endogenous hallucinog ...... ine meets the sigma-1 receptor
@nl
When the endogenous hallucinog ...... ne meets the sigma-1 receptor.
@ast
When the endogenous hallucinog ...... ne meets the sigma-1 receptor.
@en
type
label
When the endogenous hallucinog ...... ine meets the sigma-1 receptor
@nl
When the endogenous hallucinog ...... ne meets the sigma-1 receptor.
@ast
When the endogenous hallucinog ...... ne meets the sigma-1 receptor.
@en
prefLabel
When the endogenous hallucinog ...... ine meets the sigma-1 receptor
@nl
When the endogenous hallucinog ...... ne meets the sigma-1 receptor.
@ast
When the endogenous hallucinog ...... ne meets the sigma-1 receptor.
@en
P2093
P2860
P3181
P1433
P1476
When the endogenous hallucinog ...... ne meets the sigma-1 receptor.
@en
P2093
D Bruce Vaupel
Teruo Hayashi
Tsung-Ping Su
P2860
P3181
P356
10.1126/SCISIGNAL.261PE12
P407
P577
2009-03-10T00:00:00Z